Literature DB >> 15737188

Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors.

Armin Gerger1, Silvia Koller, Thomas Kern, Cesare Massone, Karin Steiger, Erika Richtig, Helmut Kerl, Josef Smolle.   

Abstract

In vivo confocal laser scanning microscopy (CLSM) represents a novel imaging tool that allows the examination of skin morphology in real time at a resolution equal to that of conventional microscopes. The aim of the study was to test the applicability of CLSM to the diagnostic discrimination of benign nevi and melanoma. five independent observers without previous experience in CLSM received a standardized instruction about diagnostic CLSM features. Subsequently, 117 melanocytic skin tumors (90 benign nevi and 27 melanoma), imaged using a commercially available, near-infrared, reflectance confocal laser scanning microscope, were evaluated by each observer. Overall, sensitivity of 88.15% and specificity of 97.60% was achieved by the five observers. Logistic regression analysis revealed that mainly cytomorphology, architecture and keratinocyte cell borders should be taken into account for diagnostic decisions. Remarkably, using the presence or absence of monomorphic melanocytes as a single diagnostic criterion, the classification results with a sensitivity of 98.15% and a specificity of 98.89% were superior to the intuitive, integrative judgement of the observers. This first sensitivity and specificity study with CLSM has yielded promising results. CLSM provides new and useful information to the clinician diagnosing melanocytic skin tumors.

Entities:  

Mesh:

Year:  2005        PMID: 15737188     DOI: 10.1111/j.0022-202X.2004.23569.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  32 in total

1.  [Confocal laser scanning microscopy].

Authors:  S Astner; M Ulrich
Journal:  Hautarzt       Date:  2010-05       Impact factor: 0.751

2.  Automated detection of malignant features in confocal microscopy on superficial spreading melanoma versus nevi.

Authors:  Dan Gareau; Ricky Hennessy; Eric Wan; Giovanni Pellacani; Steven L Jacques
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

3.  Handheld reflectance confocal microscopy to aid in the management of complex facial lentigo maligna.

Authors:  Brian P Hibler; Oriol Yélamos; Miguel Cordova; Heidy Sierra; Milind Rajadhyaksha; Kishwer S Nehal; Anthony M Rossi
Journal:  Cutis       Date:  2017-05

Review 4.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

5.  Impact of in vivo reflectance confocal microscopy on the number needed to treat melanoma in doubtful lesions.

Authors:  I Alarcon; C Carrera; J Palou; L Alos; J Malvehy; S Puig
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

Review 6.  Comparison of dermoscopy and reflectance confocal microscopy for the diagnosis of malignant skin tumours: a meta-analysis.

Authors:  Yi-Quan Xiong; Shu-Juan Ma; Yun Mo; Shu-Ting Huo; Yu-Qi Wen; Qing Chen
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-13       Impact factor: 4.553

Review 7.  Nonlinear absorption microscopy.

Authors:  Tong Ye; Dan Fu; Warren S Warren
Journal:  Photochem Photobiol       Date:  2009-01-23       Impact factor: 3.421

8.  Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia.

Authors:  Alicia L Carlson; Ann M Gillenwater; Michelle D Williams; Adel K El-Naggar; R R Richards-Kortum
Journal:  Technol Cancer Res Treat       Date:  2007-10

Review 9.  [Confocal laser scanning microscopy].

Authors:  M Ulrich
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

Review 10.  [Strategies for the noninvasive diagnosis of melanoma].

Authors:  C Fink; H A Haenssle
Journal:  Hautarzt       Date:  2016-07       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.